RVMD
Revolution Medicines, Inc.
NASDAQ · USHealthcareBiotechnology
$186.16+3.90%
Price as of Jul 17, 2026
RVMD ownership
Revolution Medicines, Inc. ownership & insider activity
Latest available institutional positioning and SEC Form 4 insider transactions, coalesced at the company entity level when listings share coverage.
Insider Activity
Sentiment
0/100
Buys (3m)
0
Sells (3m)
34
Net (3m)
-$43.4M
Insider trades by month Buys Sells
Jan
Mar
Apr
May
Jun
Jul
Context3-month price +97.2%Institutions accumulating (13F)
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Jul 1, 2026 | Patel Sushildirector | Sell | 900 | $184.59 |
| Jul 1, 2026 | Patel Sushildirector | Sell | 1,100 | $185.90 |
| Jul 1, 2026 | Patel Sushildirector | Sell | 600 | $190.54 |
| Jul 1, 2026 | Patel Sushildirector | Sell | 541 | $191.87 |
| Jul 1, 2026 | Patel Sushildirector | Sell | 858 | $186.92 |
| Jul 1, 2026 | Patel Sushildirector | Sell | 300 | $183.17 |
| Jul 1, 2026 | Patel Sushildirector | Sell | 100 | $188.57 |
| Jul 1, 2026 | Patel Sushildirector | Sell | 881 | $192.61 |
| Jul 1, 2026 | Patel Sushildirector | Option | 2,955 | $37.54 |
| Jun 26, 2026 | Anders Jackofficer: Chief Financial Officer | Sell | 300 | $170.32 |
| Jun 26, 2026 | Anders Jackofficer: Chief Financial Officer | Sell | 5,651 | $169.24 |
| Jun 26, 2026 | Anders Jackofficer: Chief Financial Officer | Sell | 4,553 | $167.34 |
| Jun 26, 2026 | Anders Jackofficer: Chief Financial Officer | Sell | 9,496 | $168.20 |
| Jun 26, 2026 | Anders Jackofficer: Chief Financial Officer | Option | 20,000 | $18.56 |
| Jun 23, 2026 | Borellini Flaviadirector | Grant | 3,127 | $162.99 |
| Jun 23, 2026 | Clyburn Frankdirector | Grant | 3,127 | $162.99 |
| Jun 23, 2026 | Horning Sandradirector | Grant | 1,191 | — |
| Jun 23, 2026 | Borellini Flaviadirector | Grant | 1,191 | — |
| Jun 23, 2026 | Clyburn Frankdirector | Grant | 1,191 | — |
| Jun 23, 2026 | Horning Sandradirector | Grant | 3,127 | $162.99 |
| Jun 23, 2026 | ANDERSON ELIZABETH Mdirector | Grant | 3,127 | $162.99 |
| Jun 23, 2026 | Kim Lorence H.director | Grant | 1,191 | — |
| Jun 23, 2026 | Patel Sushildirector | Grant | 1,191 | — |
| Jun 23, 2026 | Borisy Alexisdirector | Grant | 1,191 | — |
| Jun 23, 2026 | Kim Lorence H.director | Grant | 3,127 | $162.99 |
| Jun 23, 2026 | ANDERSON ELIZABETH Mdirector | Grant | 1,191 | — |
| Jun 23, 2026 | Borisy Alexisdirector | Grant | 3,127 | $162.99 |
| Jun 23, 2026 | Patel Sushildirector | Grant | 3,127 | $162.99 |
| Jun 18, 2026 | GOLDSMITH MARK Adirector, officer: See Remarks | Sell | 10,020 | $156.12 |
| Jun 18, 2026 | Mancini Anthonyofficer: See Remarks | Sell | 4,615 | $156.12 |
Source: RVMD SEC Form 4 filings, latest Jul 1, 2026. For informational purposes only — not investment advice.
Institutional activity (13F)
How institutions changed their RVMD positions over the last 6 months (SEC Form 13F).
Increased
324
New positions
298
Reduced
237
Sold out
73
Largest moves
| Institution | Action | Shares | Filed |
|---|---|---|---|
| VANGUARD GROUP INC | Increased | 16.7M | Jan 29, 2026 |
| FARALLON CAPITAL MANAGEMENT LLC | Increased | 14.6M | Feb 17, 2026 |
| FARALLON CAPITAL MANAGEMENT LLC | Reduced | 14.6M | Feb 17, 2026 |
| FARALLON CAPITAL MANAGEMENT LLC | Reduced | 13.6M | May 15, 2026 |
| JANUS HENDERSON GROUP PLC | Increased | 12.3M | Feb 17, 2026 |
| BLACKROCK, INC. | Increased | 11.2M | May 13, 2026 |
| JANUS HENDERSON GROUP PLC | Reduced | 9.8M | May 18, 2026 |
| BAKER BROS. ADVISORS LP | Increased | 9.6M | May 15, 2026 |
| BAKER BROS. ADVISORS LP | Unchanged | 9.5M | Feb 17, 2026 |
| BLACKROCK, INC. | Increased | 8.9M | Feb 12, 2026 |
| FMR LLC | Reduced | 8.6M | Feb 17, 2026 |
| FMR LLC | Reduced | 8.5M | May 15, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 8.4M | May 15, 2026 |
| NEXTECH INVEST, LTD. | Unchanged | 7.6M | Feb 17, 2026 |
| NEXTECH INVEST, LTD. | Unchanged | 7.6M | May 15, 2026 |
Source: SEC Form 13F filings. For informational purposes only — not investment advice.